Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 51 | 3,013−3.3%/yr | −3.3%/yr | 6.61.0× | 36% | 3,380 in 2030+1.9%/yr |
| Tumor & fibroid embolization |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 4 |
| 415+7.6%/yr |
| +7.6%/yr |
| 0.91.6× |
| 70% |
| 820 in 2030+12%/yr |
| Tumor ablation | 0 | 122−2.6%/yr | −2.6%/yr | 0.30.9× | 0% | 150 in 2030+3.4%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.